av/madrigal-pharmaceuticals-inc--big.svg

NASDAQ:MDGL

Madrigal Pharmaceuticals

  • Stock

USD

Last Close

354.85

08/11 21:00

Market Cap

6.06B

Beta: −0.62

Volume Today

454.04K

Avg: 414.20K

PE Ratio

−11.91

PFCF: −14.68

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
112K
-
471K
320.54%
405K
14.01%
467K
15.31%
527K
12.85%
gross profit
-112K
-
-471K
320.54%
-405K
14.01%
-467K
15.31%
-527K
12.85%
selling and marketing expenses
general and administrative expenses
15.70M
-
15.75M
0.30%
13.39M
14.95%
9.29M
30.63%
7.67M
17.42%
15.29M
99.34%
22.65M
48.09%
21.86M
3.46%
37.32M
70.68%
48.13M
28.97%
108.15M
124.70%
selling general and administrative expenses
15.70M
-
15.75M
0.30%
13.39M
14.95%
9.29M
30.63%
7.67M
17.42%
15.29M
99.34%
22.65M
48.09%
21.86M
3.46%
37.32M
70.68%
48.13M
28.97%
108.15M
124.70%
research and development expenses
71.86M
-
68.20M
5.09%
54.22M
20.51%
15.93M
70.61%
24.39M
53.07%
25.39M
4.10%
72.32M
184.86%
184.81M
155.53%
205.16M
11.01%
245.44M
19.63%
271.82M
10.75%
other expenses
350K
-
200K
42.86%
100K
-
273K
173%
cost and expenses
87.56M
-
83.95M
4.12%
67.61M
19.46%
25.22M
62.69%
32.06M
27.11%
40.68M
26.89%
94.97M
133.45%
206.67M
117.61%
242.48M
17.33%
293.57M
21.07%
380.50M
29.61%
operating expenses
87.56M
-
83.95M
4.12%
67.61M
19.46%
25.22M
62.69%
32.06M
27.11%
40.68M
26.89%
94.97M
133.45%
206.67M
117.61%
242.48M
17.33%
293.57M
21.07%
379.97M
29.43%
interest expense
2.63M
-
2.21M
16.07%
1.06M
51.99%
1.16M
9.71%
558K
52.06%
7.67M
1,274.73%
11.02M
43.71%
3.96M
-
12.71M
220.69%
ebitda
-87.04M
-
-83.28M
4.33%
-66.95M
19.61%
-25.22M
62.32%
-32.06M
27.11%
-40.68M
26.89%
-94.97M
133.45%
-206.67M
117.61%
-242.48M
17.33%
-291.39M
20.17%
-379.97M
30.40%
operating income
-87.56M
-
-83.95M
4.12%
-67.61M
19.46%
-25.22M
62.69%
-32.06M
27.11%
-40.68M
26.89%
-94.97M
133.45%
-206.67M
117.61%
-242.48M
17.33%
-293.57M
21.07%
-380.50M
29.61%
depreciation and amortization
516K
-
673K
30.43%
662K
1.63%
156
99.98%
77K
49,258.97%
96K
24.68%
112K
16.67%
471K
320.54%
405K
14.01%
2.19M
439.51%
527K
75.88%
total other income expenses net
-2.63M
-
-2.21M
16.07%
-1.06M
51.99%
-1.16M
9.73%
350K
130.06%
200K
42.86%
11.02M
5,412%
4.43M
59.82%
636K
85.64%
-1.78M
379.72%
6.87M
485.95%
income before tax
-90.19M
-
-86.16M
4.47%
-68.67M
20.30%
-26.39M
61.57%
-31.15M
18.06%
-32.81M
5.32%
-83.95M
155.85%
-202.24M
140.92%
-241.85M
19.58%
-295.35M
22.12%
-373.63M
26.50%
income tax expense
-373
-
-635K
170,141.29%
7.87M
1,339.53%
-11.14M
241.48%
-4.80M
56.90%
-768K
84%
3.96M
616.15%
net income
-90.19M
-
-86.16M
4.47%
-68.67M
20.30%
-26.39M
61.57%
-31.15M
18.06%
-32.81M
5.32%
-72.81M
121.91%
-197.44M
171.17%
-241.08M
22.10%
-299.31M
24.16%
-373.63M
24.83%
weighted average shs out
2.03M
-
2.81M
38.76%
171.01K
93.92%
5.20M
2,943.44%
12.24M
135.27%
14.80M
20.84%
15.39M
4.04%
15.45M
0.34%
16.54M
7.05%
17.14M
3.64%
18.69M
9.05%
weighted average shs out dil
2.03M
-
2.81M
38.76%
171.01K
93.92%
5.20M
2,943.44%
12.24M
135.27%
14.80M
20.84%
15.39M
4.04%
15.45M
0.34%
16.54M
7.05%
17.14M
3.64%
18.69M
9.05%
eps
-44.48
-
-30.62
31.16%
-401.56
1,211.43%
-5.07
98.74%
-2.54
49.90%
-2.22
12.60%
-4.73
113.06%
-12.78
170.19%
-14.58
14.08%
-17.47
19.82%
-19.99
14.42%
epsdiluted
-44.48
-
-30.62
31.16%
-401.56
1,211.43%
-5.07
98.74%
-2.54
49.90%
-2.22
12.60%
-4.73
113.06%
-12.78
170.19%
-14.58
14.08%
-17.47
19.82%
-19.99
14.42%

All numbers in USD (except ratios and percentages)